Fimea committees

The Supervision Committee is tasked with the consideration of matters concerning the issue of licences for the industrial manufacture of medicinal products, medicinal product wholesale dealer's licences, blood service licences and pharmacy licences as well as the withdrawal of these licences and any disciplinary measures.

The task of the Pharmacopoeia Committee is to submit proposals and statements on issues concerning pharmacopoeia. All of the committees serve a term of three years at a time.

Members of the Supervision Committee

Term from 7 November 2024 to 6 November 2027

Chair 
Director Susanna Peltoniemi

Vice-chair
Head of Unit Juha Sinnemäki

Members and deputy members

Director, National Supervisory Authority for Welfare and Health, Jussi Holmalahti
(Head of Unit, National Supervisory Authority for Welfare and Health, Maarit Mikkonen)
Senior Medical Officer, Vesa Mustalammi (Head of Unit, Timo Mauriala)
Jurist, Johanna Tuhola (Jurist, Juuso Haasto)

Members of the Pharmacopoeia Committee

Term from 1 March 2025 to 28 February 2028

Chair
Head of Unit Marjo-Riitta Helle

Vice-chair 
Professor Jari Yli-Kauhaluoma, University of Helsinki, Faculty of Pharmacy

Members
Head of Laboratory Tanja Tuutijärvi, University pharmacy, Analytical Laboratory
Medical Director, Jarkko Ihalainen, FRC Blood Service
Director, Kaisu Muje-Pasanen, Orion Corporation, Orion Pharma
University lecturer Katja Pajula, University of Eastern Finland, The School of Pharmacy
Professor Päivi Tammela, University of Helsinki, Faculty of Pharmacy

Secretary
Head of Section Piia Salo